AlphaMark Advisors, LLC
- SEC CIK
- 0001348183
- Latest filing
- Jan 21, 2025
NWBO holding history
Northwest Biotherapeutics Inc in every 13F filed by AlphaMark Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NWBO overviewAll 13F holders of NWBOFull Q4 2024 holdings
- Shares (Q4 2024)
- 14,007
- Value
- $4.00K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 14,007 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 14,007 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 14,007 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 14,007 | $7.00K | <0.1% | +14,007 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −14,007−100.0% | Sold out | Holders |
| Q3 2023 | 14,007 | $13.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 14,007 | $8.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 14,007 | $9.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 14,007 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 14,007 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 14,007 | $9.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 14,007 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 14,007 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 14,007 | $18.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 14,007 | $21.0K | <0.1% | +14,007 | New | Holders |